Form 4: Abbott Laboratories CEO Robert Ford Executes Stock Options and Sells Shares
SEC Form 4 Filing
Abbott Laboratories CEO Robert Ford exercised stock options and sold shares on September 12, 2024, according to a Form 4 filing with the SEC.
Summary
- On September 12, 2024, Robert B. Ford, Chairman and CEO of Abbott Laboratories, engaged in transactions involving Abbott's common stock.
- Ford exercised options to acquire 127,436 shares at $47 and 14,243 shares at $48.9.
- He then sold 80,299 shares at a weighted average price of $116.04 and 61,380 shares at a weighted average price of $116.9.
- Following these transactions, Ford directly owns 220,059 shares and indirectly owns 197,403 shares through the Ford Family Trust.
- The options were granted under the Abbott Laboratories 2009 Incentive Stock Program and are exempt from Section 16 under Rule 16b-3.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.
Industry Context
This filing is a routine disclosure of insider transactions. It's common for executives to exercise stock options and sell shares for personal financial management. The market will likely analyze the transaction for any signals about management's confidence in the company's future performance.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a form of long-term incentive.
- The exercise and sale of shares are typical activities for executives at companies like Abbott, Johnson & Johnson, and Medtronic.
- The timing and volume of these transactions are often scrutinized by investors for insights into management's perspective on the company's valuation and future prospects.
Stakeholder Impact
- Shareholders may analyze these transactions to gauge management's confidence in the company.
- The transactions themselves have a minimal direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/20/2018 | Date exercisable for some options |
| 06/01/2018 | Date exercisable for some options |
| 06/02/2014 | Date of Ford Family Trust |
| 02/19/2025 | Expiration date for some options |
| 05/31/2025 | Expiration date for some options |
| 09/12/2024 | Date of stock option exercise and share sales |
| 09/13/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.